Contact
Professor, Faculty of Medicine & Dentistry - Medicine Dept
- skar@ualberta.ca
- Phone
- (780) 492-9357
Overview
Area of Study / Keywords
neurodegenerative diseases neuroprotection neurodegeneration
About
Personal Statement:
Alzheimer’s disease is a devastating and progressive neurodegenerative disease for which we have no cure. My research is aimed at understanding the root causes of Alzheimer’s, specifically components of the neuritic plaques that kill neurons in areas of the brain, with the goal to identify potential treatments for the disease.
Neuroscientist Dr. Satyabrata Kar received his PhD from Hammersmith Hospital at the University of London. He completed post-doctoral training at Douglas Hospital, McGill University. He is professor in the Department of Medicine’s Division of Neurology and the Department of Psychiatry. He is an intramural faculty member at the Centre for Prions and Protein Folding Diseases and with the Neuroscience and Mental Health Institute.
Research
Dr. Kar’s research is concerned with the causes of neurodegeneration in people with Alzheimer’s disease and the role that insulin-like factors play in normal and Alzheimer’s brains. One
Funding and awards for his research include the Commonwealth scholarship from the UK government, Chercheur-Boursier awards from the Fonds de la Recherche en Sante du Quebec, Senior Scholar from the former Alberta Heritage Foundation for Medical Research and the Young
Teaching
Dr. Kar offers research training to undergraduate and graduate students in the field of neurodegenerative diseases.
Courses
NEURO 411 - Clinical and Basic Science Aspects of Age-related Neurodegenerative Disorders
Designed to provide senior undergraduate students in the Neuroscience program a comprehensive overview on neurobiology of various neurodegenerative disorders. Both clinical and basic science aspects of major neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington disease, Prion disease, Motor neuron disease (MND), Frontotemporal Dementia, Multiple Sclerosis and Chronic Traumatic Encephalopathy will be covered. We also intend to include a video presentation of patients with neurodegenerative disorders to outline major clinical and psychological features. In addition, papers on the most recent developments in the field of aging research have been integrated into the course. Prerequisites: NEURO 375 or PMCOL 371 or ZOOL 342 or consent from course coordinator. Credit may be obtained for either NEURO 411 or 511 but not both.
NEURO 511 - Clinical and Basic Science Aspects of Age-related Neurodegenerative Disorders
Designed to provide graduate students in the Neuroscience program a comprehensive overview on neurobiology of various neurodegenerative disorders. Both clinical and basic science aspects of major neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington disease, Prion disease, Motor neuron disease (MND), Frontotemporal Dementia, Multiple Sclerosis and Chronic Traumatic Encephalopathy will be covered. We also intend to include a video presentation of patients with neurodegenerative disorders to outline major clinical and psychological features. In addition, papers on the most recent developments in the field of aging research have been integrated into the course. Prerequisites: NEURO 375 or PMCOL 371 or ZOOL 342 or consent from course coordinator. Credit may be obtained for either NEURO 411 or 511 but not both.
Featured Publications
Wu Q, Karthivashan G, Nakhaei-Nejad M, Anand BG, Giuliani F and Kar S
International Journal of Biological Macromilecules. 2022 June; 10.1016/j.ijbiomac.2022.08.148
Anand B, Wu Q, Nakhaei-Nejad M, Karthivashan G, Dorosh L, Amidian S, Dahal A, Li X, Stepanova M, Wille H, Giuliani F and Kar S.
Bioactive Materials. 2022 June; 17 (506):525 10.1016/j.bioactmat.2022.05.030
Society for Neuroscience Meeting. 2022 May; In press
Society for Neuroscience Meeting. 2022 May; In press
Paul PS, Cho JY, Wu Q, Karthivashan G, Grabovac E, Wille H, Kulka M, Kar S
Journal of Nanobiotechnology. 2022 February; 20 (1):67 10.1186/s12951-022-01269-0
Matveychuk D, MacKenzie EM, Kumpula D, Song MS, Holt A, Kar S, Todd KG, Wood PL, Baker GB.
Cellular and Molecular Neurobiology. 2022 January; 42 (1):225-242 10.1007/s10571-021-01078-3
Grant P, Kumar J, Kar S, Overduin M.
Molecules. 2021 December; 26 (24):7669 10.3390/molecules26247669
Wu Q., Cortez L., Kamali-Jamil R., Sim V., Wille H. and Kar S.
Disease Models and Mechanisms. 2021 July; 14 (10):dmm048929 10.1242/dmm.048929
B.G. Anand, Q. Wu, G. Karthivashan, K.P. Shejale, S. Amidian, H. Wille, S. Kar
Bioactive Materials. 2021 May; 6 (12):4491-4505 10.1016/j.bioactmat
Wang Y, Wu Q, Anand B.G., Karthivashan G, Phukan G, Yang J, Thinakaran G, Westaway D and Kar S.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2020 December; 46 (7):686-706 2020-0016.R2